The Journal of Continuing Psychiatric Education – Psychiatric Annals released a feature on Transcranial Magnetic Stimulation and Neuromodulation in June. The feature was edited by TMS NeuroHealth’s very own MD Geoffrey Grammer along with Tarique Perera, MD, which includes an overview of Neuromodulation following a series of comprehensive reviews of TMS Therapy and its various uses. Dr. Grammer also co-authored one of the articles titled “The Role of rTMS in the Treatment of Psychiatric Disorders Other than Major Depression” where TMS is explored to determine its application towards other psychiatric disorders, providing compelling results of the effects TMS has on several other neurological diseases.
As an increasingly popular form of non-medicinal treatment, TMS is being developed as an extremely effective clinical technique with a clear demand from insurance companies to show support. TMS has the potential to transform the way office-based psychiatric treatment is administered and as the efficacy of this treatment improves, it could cultivate and expand the psychiatric practice as a whole.
To read the full review along with the featured articles, click here: Psychiatric Annals – Transcranial Magnetic Stimulation and Neuromodulation